The Blue Pill and Pharma : A Risky Investment ?

The legacy success of sildenafil has undeniably shaped the drug landscape. However, wagering in companies heavily dependent on generic versions and the diminishing patent rights surrounding this blockbuster medication presents a considerable degree of peril . While established pharma firms can st

read more